Yongqiang Tian Selected Research

Yongqiang Tian Research Topics

4	Neoplasms (Cancer) 02/2020 - 12/2015
2	Infections 04/2022 - 01/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Hypoxia (Hypoxemia) 10/2022
1	Cerebral Infarction 10/2022
1	Headache (Headaches) 10/2022
1	Hypertension (High Blood Pressure) 10/2022
1	Ischemia 10/2022
1	Reperfusion Injury 10/2022
1	Intracranial Vasospasm 10/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Nematode Infections 01/2022
1	Carcinoma (Carcinomatosis) 01/2016
1	Abscess 03/2013

2	Polysaccharides (Glycans)IBA 10/2022 - 01/2022
2	AlkaloidsIBA 09/2017 - 01/2016
2	Amaryllidaceae AlkaloidsIBA 01/2016 - 12/2015
1	AntioxidantsIBA 10/2022
1	CalciumIBA 10/2022
1	Free RadicalsIBA 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	CytokinesIBA 10/2022
1	Excitatory Amino AcidsIBA 10/2022
1	Phosphorus (Red Phosphorus)IBA 04/2022
1	UreaseIBA 04/2022
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 04/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	GalactosidasesIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	inositol 1-alpha-galactosyltransferaseIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	RaffinoseIBA 01/2022
1	6 beta-galactinolIBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	SugarsIBA 01/2022
1	galactinol -raffinose galactosyltransferaseIBA 01/2022
1	raffinose synthaseIBA 01/2022
1	stachyoseIBA 01/2022
1	Complex MixturesIBA 02/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	hippeastrineIBA 01/2016
1	CamptothecinIBA 01/2016
1	Cholinesterases (Cholinesterase)IBA 12/2015
1	Biological ProductsIBA 12/2015
1	muskIBA 03/2013

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022